Skip to main content

An official website of the United States government

You have 2 new alerts

BA Auto Injector RFI

Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information

  • Contract Opportunity Type: Sources Sought (Original)
  • Original Published Date: Dec 18, 2023 11:23 am CST
  • Original Response Date: Jan 17, 2024 05:00 pm CST
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Feb 01, 2024
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
    • 423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
  • Place of Performance:
    USA

Description

The AFMS is focused on providing pain relief at or very close to the wounding event, both in space and time.  A complete capability for effective, safe Battlefield Analgesia requires a systematic approach encompassing a suitable drug, a suitable and feasible route of administration, and an effective packaging and carriage device to reduce the risk of diversion and abuse.  The 10 mg Morphine Sulfate auto-injector is no longer the accepted standard and has been found in multiple cases of treatment of severe wounds to be ineffective.  Better drugs and routes of administration are known. Experience also shows that safe handling of these potent drugs with potential for diversion and abuse is possible but may require thoughtful design of the carrying device in order to reduce the risk of diversion1. 

The elements of such a system would include: 1) a drug with the appropriate pharmaceutical effects and safety profile for short-term pain relief; 2) a dosage form suitable for administration without the necessity of starting an intravenous or intraosseous infusion; and 3) formulation, storage and/or dispensing device(s) that facilitate inventory and tracking of the drug and reduce, if not prevent, its abuse and diversion1.

Contact Information

Contracting Office Address

  • CP 210 395 9550 1517 BILLY MITCHELL BLVD BLDG 954
  • SAN ANTONIO , TX 78236-0119
  • USA

Primary Point of Contact

Secondary Point of Contact





History

  • Feb 01, 2024 10:55 pm CSTSources Sought (Original)